Literature DB >> 16344443

Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas.

Mahmoud R Hussein1, Anna K Haemel, Daniel M Albert, Gary S Wood.   

Abstract

OBJECTIVES: To examine choroidal melanomas for genomic instability, manifested by microsatellite instability (MSI) and mismatch repair (MMR) protein alterations, and to determine the association of these alterations with selected clinicopathological features of the tumors.
METHODS: Polymerase chain reaction-based microsatellite assays were applied to analyze 57 cases of choroidal melanomas using 11 microsatellite markers at 5 chromosomal regions: 1p, 2p, 4q, 9p, and 17p. Immunoperoxidase staining methods and mouse monoclonal antibodies were used to investigate the expression patterns of MMR proteins.
RESULTS: Microsatellite instability was found at the 1p, 9p, and 17p regions in these lesions with an overall prevalence of 35% (20/57). The frequency of MSI ranged from 9% (1/11) to 27% (3/11), ie, low-level MSI (MSI-L). The instability was most commonly found at the 1p region (D1S2734, 55%; D1S2832, 40%; and D1S233, 20%). Two MSI banding patterns, band shifts and the appearance of additional bands, were found in 10% and 90% of the unstable lesions, respectively. The average percentages of hMLH1 and hMSH2 positively stained cells were insignificantly reduced in the unstable lesions (81.7 +/- 9.3 and 76.7 +/- 16.7) as compared with the stable lesions (84.1 +/- 15.5 and 78.6 +/- 19.6; P = .62 and 0.74 for hMLH1 and hMSH2, respectively). There was no significant difference in survival between the 2 groups; however, relative to the stable subset, the unstable tumors showed a trend (P<.10) toward occurring at a younger age and having tumor cells in vascular lakes.
CONCLUSIONS: The presence of MSI-L in some choroidal melanomas defines a novel genetic subset of these tumors and suggests that MSI (genomic instability) may play a role in their molecular pathogenesis. Elucidation of the underlying mechanisms for MSI will require further investigation. CLINICAL RELEVANCE: Detection of the MSI-L pattern might prove to be useful as an adjunct to the conventional diagnosis of choroidal melanomas. Larger series are needed to determine whether any of the correlative trends noted in this study will achieve statistical significance. To the best of our knowledge, this study is the first to define both the MSI and MMR protein expression features of choroidal melanomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344443     DOI: 10.1001/archopht.123.12.1705

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  GNAQ and PMS1 Mutations Associated with Uveal Melanoma, Ocular Surface Melanosis, and Nevus of Ota.

Authors:  Christopher B Toomey; Kyle Fraser; John A Thorson; Michael H Goldbaum; Jonathan H Lin
Journal:  Ocul Oncol Pathol       Date:  2019-01-10

2.  Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.

Authors:  Ozlem Ercelep; Turkan Ozturk Topcu; Ibrahim Vedat Bayoglu; Ahmet Siyar Ekinci; Sinan Koca; Halil Kavgaci; Melike Ozcelik; Ahmet Alacacioglu; Sernaz Uzunoglu; Oktay Bozkurt; Arife Ulas; Asude Aksoy; Burcu Yapar Taskoylu; Ozge Gumussay; Sebnem Yaman; Mukremin Uysal; Dincer Aydin; Mahmut Gumus
Journal:  Tumour Biol       Date:  2016-05-12

3.  Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?

Authors:  João Lobo; Carla Pinto; Micaela Freitas; Manuela Pinheiro; Rámon Vizcaino; Esther Oliva; Manuel R Teixeira; Carmen Jerónimo; Carla Bartosch
Journal:  Virchows Arch       Date:  2016-12-03       Impact factor: 4.064

4.  HMB45 protein expression and the immunohistochemical maturation in common blue nevi: a reappraisal.

Authors:  Mahmoud Rezk Abdelwahed Hussein
Journal:  An Bras Dermatol       Date:  2022-03-07       Impact factor: 2.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.